STAT3 and breast cancer: Based on the aforementioned results indicating the downregulation of phosphorylated STAT3, we employed a STAT3 activator (colivelin) to confirm whether sesamin attenuates MMP2 expression, cell migration, invasion, and anoikis resistance through STAT3 inhibition in BC cells.